Mechanisms of perinatal brain injury

Seminars in Neonatology

Volumn 5, Issue 1, 2000, Pages 3-16

  Inder, Terrie E ^a   Volpe, Joseph J ^b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Brain; Hypoxic ischaemic injury; Infant; Intraventricular haemorrhage; Newborn; Perinatal asphyxia; Periventricular leukomalacia; Prematurity

Indexed keywords

CYTOKINE; GLUTAMIC ACID;

BRAIN DEVELOPMENT; BRAIN HEMORRHAGE; BRAIN INJURY; CYTOKINE RELEASE; HUMAN; INTRAUTERINE INFECTION; LEUKOMALACIA; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEWBORN; PATHOGENESIS; PREMATURITY; REVIEW; WHITE MATTER;

EID: 0034017590     PISSN: 10842756     EISSN: None     Source Type: Journal    
DOI: 10.1053/siny.1999.0112     Document Type: Article

References (130)

1. Brown AW, Brierley JB. The earliest alterations in the rat neurons and astrocytes after anoxia-ischemia. Acta Neuropathol. 23:1973;9-22.
2. Kim SU. Brain hypoxia studied in mouse central nervous system cultures. 1. Sequential cellular changes. Lab Invest. 33:1975;658-669.
3. Larroche JC. Developmental Pathology of the Neonate. 1977;Excerpta Medica, New York.
4. Volpe JJ. Neurology of the Newborn. 1995;WB Saunders, Philadelphia.
5. Rivkin MJ. Hypoxic-ischemic brain injury in the term newborn. Neuropathology, clinical aspects, and neuroimaging. Clin Perinatol. 24:1997;607-625.
6. Williams CE. Outcome after ischemia in the developing sheep brain: an electroencephalographic and histological study. Ann Neurol. 31:1992;14-21.
7. Mallard EC. Frequent episodes of brief ischemia sensitize the fetal sheep brain to neuronal loss and induce striatal injury. Pediatr Res. 33:1993;61-65.
8. Mallard EC. Repeated asphyxia causes loss of striatal projection neurons in the fetal sheep brain. Neuroscience. 65:1995;827-836.
9. Mallard EC. Transient umbilical cord occlusion causes hippocampal damage in the fetal sheep. Am J Obstet Gynecol. 167:1992;1423-1430.
10. Busto R. The importance of brain temperature in cerebral ischemic injury. Stroke. 20:1989;1113-1114.
11. Minamisawa H, Smith ML, Siesjo BK. The effect of mild hyperthermia and hypothermia on brain damage following 5, 10, and 15 minutes of forebrain ischemia. Ann Neurol. 28:1990;26-33.
12. Sirimanne ES. The effect of prolonged modification of cerebral temperature on outcome after hypoxic-ischemic brain injury in the infant rat. Pediatr Res. 39:1996;591-597.
13. Gluckman PD, Williams CE. When and why do brain cells die? Dev Med Child Neurol. 34:1992;1010-1014.
14. Lorek A. Delayed ("secondary") cerebral energy failure after acute hypoxia-ischemia in the newborn piglet: continuous 48-hour studies by phosphorus magnetic resonance spectroscopy. Pediatr Res. 36:1994;699-706.
15. Penrice J. Proton magnetic resonance spectroscopy of the brain in normal preterm and term infants, and early changes after perinatal hypoxia-ischemia. Pediatr Res. 40:1996;6-14.
16. Williams CE. Pathophysiology of perinatal asphyxia. Clin Perinatol. 20:1993;305-325.
17. Orrenius S. Calcium ions and oxidative cell injury. Ann Neurol. 32:1992;S33-S42.
18. du Plessis AJ, Johnston MV. Hypoxic-ischemic brain injury in the newborn. Cellular mechanisms and potential strategies for neuroprotection. Clin Perinatol. 24:1997;627-654.
19. Choi DW. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
20. Fletcher EJ, Lodge D. New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and kainate receptors. Pharmacol Ther. 70:1996;65-89.
21. Marret S. Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol. 54:1995;358-370.
22. Johnston MV. Neurotransmitters and vulnerability of the developing brain. Brain Dev. 17:1995;301-306.
23. Gunn AJ. Flunarizine, a calcium channel antagonist, is partially prophylactically neuroprotective in hypoxic-ischemic encephalopathy in the fetal sheep. Pediatr Res. 35:1994;657-663.
24. Goplerud JM, Mishra OP, Delivoria-Papadopoulos M. Brain cell membrane dysfunction following acute asphyxia in newborn piglets. Biol Neonate. 61:1992;33-41.
25. Williams CE, Gunn A, Gluckman PD. Time course of intracellular edema and epileptiform activity following prenatal cerebral ischemia in sheep. Stroke. 22:1991;516-521.
26. Tan WK. Suppression of postischemic epileptiform activity with MK-801 improves neural outcome in fetal sheep. Ann Neurol. 32:1992;677-682.
27. Tan WK. Accumulation of cytotoxins during the development of seizures and edema after hypoxic-ischemic injury in late gestation fetal sheep. Pediatr Res. 39:1996;791-797.
28. MacManus JP. Global ischemia can cause DNA fragmentation indicative of apoptosis in rat brain. Neurosci Lett. 164:1993;89-92.
29. Beilharz EJ. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: evidence for apoptosis during selective neuronal loss. Brain Res Mol Brain Res. 29:1995;1-14.
30. Marks KA. Delayed vasodilation and altered oxygenation after cerebral ischemia in fetal sheep. Pediatr Res. 39:1996;48-54.
31. Marks KA. Nitric oxide synthase inhibition attenuates delayed vasodilation and increases injury after cerebral ischemia in fetal sheep. Pediatr Res. 40:1996;185-191.
32. Mallard EC. Neuronal damage in the developing brain following intrauterine asphyxia. Reprod Fertil Dev. 7:1995;647-653.
33. Gunn AJ. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal lambs. J Clin Invest. 99:1997;248-256.
34. Roth SC. Relation of deranged neonatal cerebral oxidative metabolism with neurodevelopmental outcome and head circumference at 4 years. Dev Med Child Neurol. 39:1997;718-725.
35. Volpe JJ. Brain injury in the premature infant. Neuropathology, clinical aspects, pathogenesis, and prevention. Clin Perinatol. 24:1997;567-587.
36. Hack M, Friedman H, Fanaroff AA. Outcomes of extremely low birth weight infants. Pediatrics. 98:1996;931-937.
37. Horbar JD. Vermont-Oxford Network 1997 Database Summary. 1997;Vermont-Oxford Network, Burlington.
38. Network AaNZN. Australian and New Zealand Neonatal Network Series number 2. 1995;Australian Institute of Health and Welfare Perinatal Statistics Unit, Sydney.
39. Arch Dis Child Fetal Neonatal Ed. 77:1997;F91-F94.
40. Pharoah PO, Platt MJ, Cooke T. The changing epidemiology of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 75:1996;F169-F173.
41. Pharoah PO. Birthweight specific trends in cerebral palsy. Arch Dis Child. 65:1990;602-606.
42. Piecuch RE. Outcome of extremely low birth weight infants (500 to 999 grams) over a 12-year period. Pediatrics. 100:1997;633-639.
43. Powls A. Visual impairment in very low birthweight children. Arch Dis Child Fetal Neonatal Ed. 76:1997;F82-F87.
44. Skranes JS. Cerebral magnetic resonance imaging and mental and motor function of very low birth weight children at six years of age. Neuropediatrics. 28:1997;149-154.
45. Singer L. A longitudinal study of developmental outcome of infants with bronchopulmonary dysplasia and very low birth weight. Pediatrics. 100:1997;987-993.
46. McMenamin JB, Shackelford GD, Volpe JJ. Outcome of neonatal itravetricular haemorrhage with periventricular echodense lesions. Ann Neurol. 15:1984;285-290.
47. Levene MI, Wigglesworth JS, Dubowitz V. Cerebral structure and intraventricular hemorrhage in the neonate: a real time ultrasound study. Arch Dis Child. 56:1981;416-424.
48. Holt PJ, Allan WF. The natural history of ventrisular dilatation in neonatal intraventricular hemorrhage and its therapeutic implication. Ann Neurol. 10:1981;293.
49. Ahmann PA. Intraventricular hemorrhage in the high-risk preterm infant: incidence and outcome. Ann Neurol. 7:1980;118-124.
50. Paneth N. Incidence and timing of germinal matrix/intraventricular hemorrhage in low birth weight infants. Am J Epidemiol. 137:1993;1167-1176.
51. Philip AG. Intraventricular hemorrhage in preterm infants: declining incidence in the 1980s. Pediatrics. 84:1989;797-801.
52. Guzzetta F. Periventricular intraparenchymal echodensities in the premature newborn: critical determinant of neurologic outcome. Pediatrics. 78:1986;995-1006.
53. Gould SJ. Periventricular intraparenchymal cerebral haemorrhage in preterm infants: the role of venous infarction. J Pathol. 151:1987;197-202.
54. Flodmark O. Correlation between computed tomography and autopsy in premature and full-term neonates that have suffered perinatal asphyxia. Radiology. 137:1980;93-103.
55. Armstrong DL, Sauls CD, Goddard-Finegold J. Neuropathologic findings in short-term survivors of intraventricular hemorrhage. Am J Dis Child. 141:1987;617-621.
56. Volpe JJ. Positron emission tomography in the newborn: extensive impairment of regional cerebral blood flow with intraventricular hemorrhage and hemorrhagic intracerebral involvement. Pediatrics. 72:1983;589-601.
57. Rushton DI, Preston PR, Durbin GM. Structure and evolution of echo dense lesions in the neonatal brain. A combined ultrasound and necropsy study. Arch Dis Child. 60:1985;798-808.
58. Takashima S, Mito T, Ando Y. Pathogenesis of periventricular white matter hemorrhages in preterm infants. Brain Dev. 8:1986;25-30.
59. Perlman JM. Relationship between periventricular intraparenchymal echodensities and germinal matrix-intraventricular hemorrhage in the very low birth weight neonate. Pediatrics. 91:1993;474-480.
60. Ment LR. Risk factors for early intraventricular hemorrhage in low birth weight infants. J Pediatr. 121:1992;776-783.
61. Taylor GA. Effect of germinal matrix hemorrhage on terminal vein position and patency. Pediatr Radiol. 25:1995;S37-S40.
62. Banker BQ, Larroche JC. Periventricular leukomalacia of infancy. Arch Neurol. 7:1962;386-410.
63. Back SA, Volpe JJ. Cellular and molecular pathogenesis of periventricular white matter injury. MRDD Res Rev. 3:1997;96-107.
64. Barth PG. On the relationship between germinal layer haemorrhage and telencephalic leucoencephalopathy in the preterm infant. Neuropadiatrie. 11:1980;17-26.
65. Carson SC. Value of sonography in the diagnosis of intracranial hemorrhage and periventricular leukomalacia: a postmortem study of 35 cases. AJR Am J Roentgenol. 155:1990;595-601.
66. Dammann O, Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr Res. 42:1997;1-8.
67. de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res. 49:1992;1-6.
68. de Vries LS. Correlation between the degree of periventricular leukomalacia diagnosed using cranial ultrasound and MRI later in infancy in children with cerebral palsy. Neuropediatrics. 24:1993;263-268.
69. Golden JA. Frequency of neuropathological abnormalities in very low birth weight infants. J Neuropathol Exp Neurol. 56:1997;472-478.
70. Hope PL. Precision of ultrasound diagnosis of pathologically verified lesions in the brains of very preterm infants. Dev Med Child Neurol. 30:1988;457-471.
71. Iida K, Takashima S, Ueda K. Immunohistochemical study of myelination and oligodendrocyte in infants with periventricular leukomalacia. Pediatr Neurol. 13:1995;296-304.
72. Leviton A, Gilles FH. Acquired perinatal leukoencephalopathy. Ann Neurol. 16:1984;1-8.
73. Paneth N. White matter necrosis in very low birth weight infants: neuropathologic and ultrasonographic findings in infants surviving six days or longer. J Pediatr. 116:1990;975-984.
74. Perlman JM, Risser R, Broyles RS. Bilateral cystic periventricular leukomalacia in the premature infant: associated risk factors. Pediatrics. 97:1996;822-827.
75. Takashima S, Iida K, Deguchi K. Periventricular leukomalacia, glial development and myelination. Early Hum Dev. 43:1995;177-184.
76. Yoon BH. Interleukin-6 concentrations in umbilical cord plasma are elevated in neonates with white matter lesions associated with periventricular leukomalacia. Am J Obstet Gynecol. 174:1996;1433-1440.
77. Yoon BH. High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia. Am J Obstet Gynecol. 177:1997;406-411.
78. Zupan V. Periventricular leukomalacia: risk factors revisited. Dev Med Child Neurol. 38:1996;1061-1067.
79. Hesser U. Diagnosis of intracranial lesions in very-low-birthweight infants by ultrasound: incidence and association with potential risk factors. Acta Paediatr Suppl. 419:1997;16-26.
80. Holling EE, Leviton A. Characteristics of cranial ultrasound white-matter echolucencies that predict disability: a review. Dev Med Child Neurol. 41:1999;136-139.
81. Iida K. Neuropathologic study of newborns with prenatal-onset leukomalacia. Pediatr Neurol. 9:1993;45-48.
82. Dambska M, Laure-Kamionowska M, Schmidt-Sidor B. Early and late neuropathological changes in perinatal white matter damage. J Child Neurol. 4:1989;291-298.
83. Rodriguez J. Periventricular leukomalacia: ultrasonic and neuropathological correlations. Dev Med Child Neurol. 32:1990;347-352.
84. Takashima S. Relationship between periventricular hemorrhage, leukomalacia and brainstem lesions in prematurely born infants. Brain Dev. 11:1989;121-124.
85. Gilles FH, Leviton A, Dooling EC. The Developing Human Brain: Growth and Epidemiologic Neuropathology. 1983;John Wright, Boston.
86. Rorke LB. Pathology of Perinatal Brain Injury. 1982;Raven Press, New York.
87. Reuck JD. The human periventricular arterial blood supply and the anatomy of cerebral infarctions. Eur Neurol. 5:1971;321-334.
88. Reuck JD, Chatta AS, Richardson EP. Pathogenesis and evolution of periventricular leukomalacia in infancy. Arch Neurol. 27:1972;229-236.
89. Reuck JD. Cerebral angioarchitecture and perinatal brain lesions in premature and full term infants. Acta Neurol Scand. 70:1984;391-395.
90. Rorke LB. Anatomical features of the developing brain implicated in pathogenesis of hypoxic-ischemic injury. Brain Pathol. 2:1992;211-221.
91. Takashima S, Tanaka K. Development of cerebrovascular architecture and its relationship to periventricular leukomalacia. Arch Neurol. 35:1978;11-16.
92. Takashima S. Pathology on neonatal hypoxic brain damage and intracranial hemorrhage. Factors important in their pathogenesis. International Congress Series No. 579, Child Neurology. 1982;Excerpta Medica, Amsterdam.
93. Altman DI. Cerebral blood flow requirement for brain viability in newborn infants is lower than in adults. Ann Neurol. 24:1988;218-226.
94. Greisen G. Cerebral blood flow in preterm infants during the first week of life. Acta Paediatr Scand. 75:1986;43-51.
95. Greisen G, Trojaborg W. Cerebral blood flow, PaCO2 changes, and visual evoked potentials in mechanically ventilated, preterm infants. Acta Paediatr Scand. 76:1987;394-400.
96. Greisen G, Pryds O. Low CBF, discontinuous EEG activity, and periventricular brain injury in ill, preterm neonates. Brain Dev. 11:1989;164-168.
97. Pryds O, Greisen G, Friis-Hansen B. Compensatory increase of CBF in preterm infants during hypoglycaemia. Acta Paediatr Scand. 77:1988;632-637.
98. Pryds O. Heterogeneity of cerebral vasoreactivity in preterm infants supported by mechanical ventilation. J Pediatr. 115:1989;638-645.
99. 2and haemoglobin concentration on day to day variation of CBF in preterm neonates. Acta Paediatr Scand Suppl. 360:1989;33-36.
100. Pryds O, Greisen G. Preservation of single-flash visual evoked potentials at very low cerebral oxygen delivery in preterm infants. Pediatr Neurol. 6:1990;151-158.
101. Lou HC. Pressure passive cerebral blood flow and breakdown of the blood-brain barrier in experimental fetal asphyxia. Acta Paediatr Scand. 68:1979;57-63.
102. Younkin DP. The effect of hematocrit and systolic blood pressure on cerebral blood flow in newborn infants. J Cereb Blood Flow Metab. 7:1987;295-299.
103. Pryds O. Contorl of cerebral circulation in the high-risk neonate. Ann Neurol. 30:1991;321-329.
104. Wiswell TE. Effects of hypocarbia on the development of cystic periventricular leukomalacia in premature infants treated with high-frequency jet ventilation. Pediatrics. 98:1996;918-924.
105. Graziani LJ. Clinical antecedents of neurologic and audiologic abnormalities in survivors of neonatal extracorporeal membrane oxygenation. J Child Neurol. 12:1997;415-422.
106. Fujimoto S. Hypocarbia and cystic periventricular leukomalacia in premature infants. Arch Dis Child. 71:1994;F107-F111.
107. Calvert SA. Periventricular leukomalacia: ultrasonic diagnosis and neurological outcome. Act Paed Scand. 75:1986;489-496.
108. Ikeda T. Physiologic and histologic changes in near-term fetal lambs exposed to asphyxia by partial umbilical cord occlusion. Am J Obstet Gynecol. 178:1998;24-32.
109. Reddy K. Maturational change in the cortical response to hypoperfusion injury in the fetal sheep. Pediatr Res. 43:1998;674-682.
110. Williams CE. Cerebral ischemic injury in the preterm fetal sheep leads ot specific white matter lesions. Pediatric research. 1999.
111. Towfighi J. Neuropathology of remote hypoxic-ischemic damage in the immature rat. Acta Neuropathol. 81:1991;578-587.
112. Sheldon RA, Chuai J, Ferriero DM. A rat model for hypoxic-ischemic brain damage in very premature infants. Biol Neonate. 69:1996;327-341.
113. Back SA. Maturation-dependent vulnerability of oligodendrocytes to death induced by glutathione depletion. Soc Neurosci Abstr. 1997.
114. Oka A. Vulnerability of oligodendroglia to glutamate: pharmacology, mechanism and prevention. J Neuroscience. 13:1993;1441-1453.
115. Yonezawa M. Cystine deprivation induces oligodendroglial death: rescue by free radical scavengers and by a diffuse glial factor. J Neurochem. 67:1996;566-573.
116. Connor JR, Fine RE. Development of transferrin-positive oligodendrocytes in the rat central nervous system. J Neurosci Res. 17:1987;51-59.
117. Connor JR, Menzies SL. Altered cellular distribution of iron in thecentral nervous system of myelin deficient rats. Neuroscience. 34:1990;265-271.
118. Connor JR, Menzies SL. Relationship of iron to oligodendrocytes and myelination. Glia. 17:1996;83-93.
119. Gilles FH, Leviton A, Kerr CS. Suspectibility of the neonatal feline telencephalic white matter to a lipopolysaccharide. J Neurol Sci. 27:1976;183-191.
120. Gilles FH, Averill DR Jr, Kerr CS. Neonatal endotoxin encephalopathy. Ann Neurol. 2:1977;49-56.
121. Yoon BH. Experimentally induced intrauterine infection causes fetal brain white matter lesions in rabbits. Am J Obstet Gynecol. 177:1997;797-802.
122. O'Shea TM. Intrauterine infection and the risk of cerebral palsy in very low-birthweight infants. Paediatr Perinat Epidemiol. 12:1998;72-83.
123. Yoon BH. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1 beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am J Obstet Gynecol. 177:1997;19-26.
124. Deguchi K, Mizuguchi M, Takashima S. Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr Neurol. 14:1996;13-16.
125. Deguchi K, Oguchi K, Takashima S. Characteristic neuropathology of leukomalacia in extremely low birth weight infants. Pediatr Neurol. 16:1997;296-300.
126. Meng SZ. Early detection of axonal and neuronal lesions in prenatal-onset periventricular leukomalacia. Brain Dev. 19:1997;480-484.
127. Beneveniste H. The excitotoxin hypothesis in relation to cerebral ischemia. Cerebrovasc Metab Rev. 3:1991;213-245.
128. Battistin L, Grynbaum A, Lajtha A. The uptake of various amino acids by the mouse brain in vivo. Brain Res. 29:1971;85-99.
129. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem. 42:1984;1-11.
130. Yoshioka A, Bacskai B, Pleasure D. Pathophysiology of oligodendroglial excitotoxicity. J Neurosci Res. 46:1996;427-438.